e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Tobacco addiction: prevention and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Symptom of pulmonary arterial hypertension in patients-smokers and ex-smokers with COPD and in patients-smokers and non-smokers with bronchial asthma (BA)
T. V. Bednarzhevskaya, Y. N. Shoiket (Barnaul, Russia)
Source:
Annual Congress 2004 - Tobacco addiction: prevention and treatment
Session:
Tobacco addiction: prevention and treatment
Session type:
Poster Discussion
Number:
3091
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. V. Bednarzhevskaya, Y. N. Shoiket (Barnaul, Russia). Symptom of pulmonary arterial hypertension in patients-smokers and ex-smokers with COPD and in patients-smokers and non-smokers with bronchial asthma (BA). Eur Respir J 2004; 24: Suppl. 48, 3091
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Pulmonary hypertension at the patients with bronchial asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 58s
Year: 2004
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004
Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Airway pathology in COPD compared to that in smokers with asthma
Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities
Year: 2008
Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Prevalence of airflow obstruction in smokers and never-smokers in Switzerland
Source: Eur Respir J 2010; 36: 1259-1269
Year: 2010
Bronchial vascularity in the airways of chronic bronchitis and COPD smokers
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007
Pulmonary vascular remodelling in COPD versus bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003
Inflammation of airways and results of 6-MWT at smokers with bronchial asthma.
Source: International Congress 2017 – Smoking and molecular findings
Year: 2017
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Source: Eur Respir J 2002; 19: 632-638
Year: 2002
Does knowledge of smokers about chronic obstructive pulmonary disease (COPD) differ than nonsmokers?
Source: Eur Respir J 2004; 24: Suppl. 48, 372s
Year: 2004
Chronic obstructive pulmonary disease in smokers with asthma
Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission
Year: 2011
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Source: Eur Respir J 2005; 26: 835-845
Year: 2005
Smoking habit and bronchial hyperresponsiveness in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 39s
Year: 2006
Systemic inflammation and pulmonary hypertension in patients with bronchial asthma
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Pulmonary artery diameter and nocturnal hypoxemia in smokers with/without COPD.
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018
Analysis of pulmonary circulation impairments in occupational bronchitis (OB) among smokers and nonsmokers
Source: Eur Respir J 2001; 18: Suppl. 33, 252s
Year: 2001
The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008
Airway T-lymphocytes expressing IFN-γ are reduced in smokers with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 6s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept